On Invalid Date, Dermata Therapeutics (NASDAQ: DRMA) reported Q1 2023 earnings per share (EPS) of -$2.27, up 57.57% year over year. Total Dermata Therapeutics earnings for the quarter were -$2.24 million. In the same quarter last year, Dermata Therapeutics's earnings per share (EPS) was -$5.35.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.